Sonova (OTCMKTS:SONVY) Shares Gap Up - Still a Buy?

Key Points

• Shares of Sonova Holding gapped up from $55.34 to $57.42, last trading at $57.49 with a volume of 7,687 shares.
• Equities analysts have recently increased their ratings on Sonova, with Zacks Research upgrading it to a "strong-buy" rating, while BNP Paribas initiated coverage with an "underperform" rating.
• The company's financials indicate a debt-to-equity ratio of 0.45 and a current ratio of 1.27, suggesting a stable financial position.

Shares of Sonova Holding (OTCMKTS:SONVY - Get Free Report) gapped up before the market opened on Wednesday . The stock had previously closed at $55.34, but opened at $57.42. Sonova shares last traded at $57.49, with a volume of 7,687 shares trading hands.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the company. Zacks Research raised Sonova from a "hold" rating to a "strong-buy" rating in a research note on Thursday, October 16th. Rothschild Redb raised Sonova from a "strong sell" rating to a "hold" rating in a research note on Monday, October 6th. Sanford C. Bernstein upgraded Sonova from a "hold" rating to a "strong-buy" rating in a research report on Friday, July 18th. Finally, BNP Paribas initiated coverage on Sonova in a research report on Monday. They set an "underperform" rating for the company. Two research analysts have rated the stock with a Strong Buy rating, four have given a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Hold".

Sonova Price Performance

The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.96 and a current ratio of 1.27. The company has a fifty day moving average price of $57.07 and a 200-day moving average price of $58.84.

Sonova Company Profile

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.